APA

Peña-Quintana L., Scherer G., Curbelo-Estévez M. L., Jiménez-Acosta F., Hartmann B., La Roche F., Meavilla-Olivas S., Pérez-Cerdá C., García-Segarra N., Giguère Y., Huppke P., Mitchell G. A., Mönch E., Trump D., Vianey-Saban C., Trimble E. R., Vitoria-Miñana I., Reyes-Suárez D., Ramírez-Lorenzo T. & Tugores A. (20180430). Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. : Clinical genetics.

Chicago

Peña-Quintana L, Scherer G, Curbelo-Estévez M L, Jiménez-Acosta F, Hartmann B, La Roche F, Meavilla-Olivas S, Pérez-Cerdá C, García-Segarra N, Giguère Y, Huppke P, Mitchell G A, Mönch E, Trump D, Vianey-Saban C, Trimble E R, Vitoria-Miñana I, Reyes-Suárez D, Ramírez-Lorenzo T and Tugores A. 20180430. Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. : Clinical genetics.

Harvard

Peña-Quintana L., Scherer G., Curbelo-Estévez M. L., Jiménez-Acosta F., Hartmann B., La Roche F., Meavilla-Olivas S., Pérez-Cerdá C., García-Segarra N., Giguère Y., Huppke P., Mitchell G. A., Mönch E., Trump D., Vianey-Saban C., Trimble E. R., Vitoria-Miñana I., Reyes-Suárez D., Ramírez-Lorenzo T. and Tugores A. (20180430). Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. : Clinical genetics.

MLA

Peña-Quintana L, Scherer G, Curbelo-Estévez M L, Jiménez-Acosta F, Hartmann B, La Roche F, Meavilla-Olivas S, Pérez-Cerdá C, García-Segarra N, Giguère Y, Huppke P, Mitchell G A, Mönch E, Trump D, Vianey-Saban C, Trimble E R, Vitoria-Miñana I, Reyes-Suárez D, Ramírez-Lorenzo T and Tugores A. Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. : Clinical genetics. 20180430.